Evaluation of GSK Biologicals' Boostrix™ Polio in Healthy Adults, 10 Years After a Booster Vaccination [EXTENSION OF 700196776]

Trial Profile

Evaluation of GSK Biologicals' Boostrix™ Polio in Healthy Adults, 10 Years After a Booster Vaccination [EXTENSION OF 700196776]

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2017

At a glance

  • Drugs DTaP poliovirus vaccine (Primary) ; DT-poliovirus vaccine; DTaP vaccine; Poliovirus vaccine inactivated
  • Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline; GlaxoSmithKline Biologicals
  • Most Recent Events

    • 21 Mar 2014 New source identified and integrated: European Clinical Trials Database record (EudraCT2009-012219-16).
    • 20 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top